Literature DB >> 8880163

Morphometric analysis of gastrocnemius muscle fiber size and fiber proportions in the hypophysectomized rat after prolonged administration of growth hormone or thyroxine.

A V Everitt1, V Terry, M J Phillips, H M Kerry, C D Shorey.   

Abstract

This study investigated the effects of either growth hormone or thyroxine on muscle fiber atrophy caused by hypophysectomy in male Wistar rats. Muscle fiber size is reported as equivalent circle diameter (ECD) in transverse section of fresh-frozen gastrocnemius muscle. Three months post-hypophysectomy type 1 (slow twitch) and type 2 (fast twitch) muscle fibers were smaller (p < 0.01) than those in intact controls as shown previously in this laboratory. The administration of human growth hormone (GH) (50mIU/100g body weight/day) to hypophysectomized (hypox) rats for 42 days, stimulated body growth, restored 42% of the lost gastrocnemius muscle weight (p < 0.05) and 36% of the lost type 1 fiber size, (p < 0.01), but had no effect on type 2 fiber size. Treatment of hypox rats with physiological doses of thyroxine (5 micrograms T4/100g body weight/alternate day) for 42 days did not affect body growth, gastrocnemius muscle weight or type 1 fiber size, but reduced the size of type 2 fibers (p < 0.01). Thyroxine prevented the decline in the percentage of type 2 fibers which occurs after hypophysectomy. This unique observation suggests that thyroid hormone regulates the proportion of different fiber types in the gastrocnemius muscle. Thus, in hypox rats, GH promoted growth of type 1 or slow twitch muscle fibers needed to support the increasing weight of the growing body. Physiological doses of T4 did not stimulate growth, but caused further atrophy of of type 2 fibers possibly while providing fuel for rapid movement.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880163

Source DB:  PubMed          Journal:  Growth Dev Aging        ISSN: 1041-1232


  5 in total

Review 1.  Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.

Authors:  Darlene E Berryman; Jens Sandahl Christiansen; Gudmundur Johannsson; Michael O Thorner; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2008-08-16       Impact factor: 2.372

Review 2.  Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults.

Authors:  Silvia Giovannini; Emanuele Marzetti; Stephen E Borst; Christiaan Leeuwenburgh
Journal:  Mech Ageing Dev       Date:  2008-08-13       Impact factor: 5.432

3.  The effect of different patterns of growth hormone administration on the IGF axis and somatic and skeletal growth of the dwarf rat.

Authors:  Melissa Westwood; Arfa R Maqsood; Mattea Solomon; Andrew J Whatmore; Julian R E Davis; Robert C Baxter; Evelien F Gevers; Iain C A F Robinson; Peter E Clayton
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-10-27       Impact factor: 4.310

4.  Growth Hormone and Craniofacial Tissues. An update.

Authors:  George Litsas
Journal:  Open Dent J       Date:  2015-01-30

Review 5.  GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice.

Authors:  Betina Biagetti; Rafael Simó
Journal:  Int J Mol Sci       Date:  2021-01-02       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.